您的位置: 首页 > 农业专利 > 详情页

FORMULATIONS ORALES ET UTILISATIONS DE CELLES-CI
专利权人:
EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO)
发明人:
VANKAN, PIERRE,SASARMAN, ANDREEA,WILLMBRINK, GRASIELA BOURSCHEIT
申请号:
CA3089656
公开号:
CA3089656A1
申请日:
2019.02.01
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Disclosed are therapeutic oral formulations comprising particular substituted pyridine based compounds, their manufacture, and methods and uses of said formulations in treating substance P mediated pathways in the brain such as elevated intracranial pressure or the modification of expression of (hyper)-phosphorylated tau protein (t) in the brain for indications such as, but not limited to concussion, post-concussive (or post-concussion) syndrome (PCS), chronic traumatic encephalopathy (CTE), traumatic brain injury (TBI) and stroke.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充